Inovio Pharmaceuticals financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$1.17M $5.47M $3.47M $4.81M $2.10M $9.12M $6.14M $9.80M $4.12M $13.47M $10.46M $40.57M $35.37M $42.22M $30.48M $4.11M $7.41M $1.77M $10.26M $0.83M $0.00M
GM % Gross Margin %
0.00% -99.40% -131.27% -90.03% -154.02% 3.41% -105.86% -104.51% 0.00% -58.67% -226.06% -42.44% -150.82% -133.47% -212.51% 0.00% 100.00% 0.00% 0.00% 100.00% 0.00%
OM Operating Margin
0.00% -222.69% 0.00% 0.00% 0.00% -153.04% 0.00% -226.90% 0.00% -159.97% 0.00% -86.97% -218.38% -200.48% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$-2.52 $-1.84 $-1.08 $-1.20 $-0.80 $-0.64 $-0.50 $-0.61 $-1.44 $-0.61 $-0.43 $-1.01 $-1.08 $-1.05 $-1.21 $-0.83 $-1.45 $-1.17 $-6.09 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 -0.00% -0.00% 0 0 -0.00% -0.00% -0.00% 0
Sha. Shares
4.58m 4.88m 8.88m 10.95m 11m 25.53m 26.05m 33.74m 34.84m 52.09m 60.59m 72.18m 74.06m 90.3m 95.35m 100.01m 167.52m 206.75m 210.39m 272.99m 22.75m
OCF Operating Cash Flow
$-6.80M $-12.31M $-7.04M $-11.51M $-11.13M $-14.08M $-11.94M $-19.76M $-22.31M $-15.38M $-29.82M $-12.44M $-62.56M $-63.21M $-73.55M $-97.85M $-177.98M $-215.71M $-216.22M $-124.37M $0.00M
FCF Free Cash Flow
$-6.90M $-12.60M $-7.09M $-11.65M $-11.25M $-14.13M $-12.12M $-19.92M $-22.55M $-15.56M $-31.20M $-15.22M $-65.30M $-73.50M $-75.64M $-98.84M $-179.50M $-216.94M $-217.18M $-135.00M $0.00M
FCFS Free Cash Flow Per Share
$-1.71 $-2.87 $-1.08 $-1.17 $-1.07 $-0.76 $-0.47 $-0.62 $-0.64 $-0.29 $-0.53 $-0.21 $-0.89 $-0.89 $-0.82 $-1.00 $-1.16 $-1.04 $-10.92 $-5.62 $0.00